Medicare AdvantageCoverageMedium impact
MA06.025r, Presumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments
Independence Blue Cross·Pain Management, Psychiatry, Family Medicine +1 more·Pharmacy
Effective date
Jun 25, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA06.025r regarding presumptive and definitive drug testing for substance abuse and pain management treatments has been reissued and will become effective June 25, 2025. This is a policy update that may affect coverage criteria, billing requirements, or prior authorization for drug testing services in these specific treatment contexts.
Action Required
Before June 25, 2025: Billing team should review the full policy details at the provided URL to identify specific changes to drug testing coverage, billing requirements, or prior authorization for substance abuse and pain management patients with Medicare Advantage plans. Update billing procedures and staff training accordingly once full policy content is available.